34 drugs added, 26 dropped from list of essential medicine

Bleaching powder and ranitidine, a common antacid sold under some of the most popular medicine brands in India, were amongst the ones dropped from the list of National List of Essential Medicines (NLEM) 2022 even as nicotine replacement therapy (NRT) and TB & diabetics treatment drugs were among the latest addition to the list. As … Read more

Stock Market Today: Dow Drops After Hawkish Remarks From Powell

Text size Fed Chairman Jerome Powell’s speech scheduled for Friday has hung over markets all week. Drew Angerer/Getty Images The stock market was falling Friday, as Federal Reserve Chairman Jerome Powell made hawkish remarks about monetary policy at the annual Jackson Hole Symposium, even in the face of declining inflation. After Powell’s comments, the Dow … Read more

Novavax slashes sales guidance in half, stock plunges 34%

Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial expectations, sending shares down more than 30% in after-hours trading. Novavax NVAX, -5.01% now projects total 2022 revenue of $2 billion to $2.3 billion, after previously stating a goal of $4 billion to $5 billion. The U.S. Food and Drug … Read more

Disney, Coinbase, BioNTech, Rivian, and Other Stocks to Watch This Week

Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tyson Foods , BioNTech , AIG, and Take-Two Interactive Software will report. Coinbase Global, Norwegian Cruise Line Holdings , Sysco , and Ralph Lauren go on … Read more

New way to short Tesla with AXS Investments ETF

Investors have a new way to make bullish and bearish bets on large-cap stocks. AXS Investments launched eight of 18 approved single-stock leveraged ETFs this month. The funds aim to increase exposure of short-term single-stock investments. “They’re designed for active traders, traders that are looking to make tactical trading decisions on a daily basis,” the … Read more

25 Stocks That Could Rise on a Short Squeeze

Investors betting against electric-vehicle stocks take note: Five of 25 stocks that short-selling research firm S3 Partners identified this month as being at risk of a short squeeze are in the EV business. Short sellers fear short squeezes. To put on a short, investors borrow shares. If the stock falls, the short seller buys them … Read more

Why Is the Stock Market Down Today? Dow Sinks as Inflation Soars.

Text size The Federal Reserve under Jerome Powell is expected to continue raising interest rates. Olivier Douliery/AFP via Getty Images The stock market was sinking after inflation came in hotter-than-expected in June.  The Dow Jones Industrial Average has declined 334.83 points, or 1.1%, while the S&P 500 has fallen 1.4%, and the Nasdaq Composite futures … Read more

Warren Buffett’s Berkshire Hathaway reveals new stakes in Paramount, Citigroup

OMAHA, Neb. — Warren Buffett’s company on Monday revealed all the investment moves it made in the first quarter, when it spent more than $51 billion on stocks. But Buffett had already shared the biggest investments with Berkshire Hathaway BRK.A, -0.16% BRK.B, -0.34% shareholders at the company’s recent annual meeting. That means investors already knew that … Read more

Johnson & Johnson Suspends Vaccine Sales Guide, Boosts Dividend

Updated at 9:59 am EST Johnson & Johnson  (JNJ) – Get Johnson & Johnson Report posted stronger-than-expected first quarter earnings Tuesday but lowered its full-year profit forecast, and suspended its guidance for vaccine sales amid what it called a global surplus and waning demand.  Johnson & Johnson said adjusted earnings for the three months ending in … Read more

Stocks for the Recession That May—or May Not—Be Coming

Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week—and that’s a recession signal that is either like Paul Revere’s ride or the boy who cried wolf. The good news: Investors don’t need to decide which just yet. The yield curve … Read more